Producing booklet for appropriate application of amyloid PET imaging in people with dementia. (Relationship between clnical symptoms and amyloid PET binding in early dementia subjects.)

Producing booklet for appropriate application of amyloid PET imaging in people with dementia. (Relationship between clnical symptoms and amyloid PET binding in early dementia subjects.) - Producing booklet for amyloid PET imaging

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031729

Enrollment

Registered

2018-03-31

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Interventions

Florbetapir PET scanned once.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Atypical clinical symptom or age of onset for dementia. (2)Mild to moderate cognitive impairment.

Exclusion criteria

Exclusion criteria: (1)Delirium (2)Depression (3)Drug induced cognitive decline (4)Pregnancy

Design outcomes

Primary

Measure	Time frame
Diagnostic change of subject with dementia by result from florbetapir PET imaging.	—

Secondary

Measure	Time frame
Adverse effect of florbetapir PET.	—

Countries

Japan

Contacts

Public ContactShigeki Hirano

Chiba University Hospital Clinical Trial Department

s_hirano@chiba-u.jp043-226-2736

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026